
Genenta Science
Biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.
Market cap
$69.5m
Enterprise value
$55m
Share price
$3.80 GNTA
Company register number
MI2045555
Authorizing premium user...
Biotechnology company that develops gene transfer therapy for the treatment of cancer tumors.